An industry pioneer & leader

Plexus Ventures was formed in 1990 by John F. Chappell, former Chairman of SmithKline Beecham Worldwide Pharmaceuticals (now GlaxoSmithKline). In 1991 Bob Moran joined the company after 15 years with SmithKline Beecham and now serves as the senior member of the Plexus team.

During its early years, Plexus Ventures focused on investments in
early-stage companies developing novel compounds or drug delivery technologies. In recent years, Plexus has refocused its efforts to provide clients with consulting services, delivering business development expertise and strategic advice to pharmaceutical, biotechnology, and drug delivery firms worldwide.

Plexus Ventures has emerged as a leader in pharmaceutical business development with an impressive record of deal successes. We combine global reach and local knowledge through our team of dedicated professionals located in cities throughout the United States, Europe, Japan and China.

In 2010, Plexus Ventures achieved the significant milestone of 20
years in business. To coincide with this important anniversary, Plexus Ventures announced expanded service offerings including Portfolio Management, Financial Analysis and Deal Valuation, Supply Chain Sourcing, Commercial and Scientific Due Diligence, Pre and Post Project Analysis.

Through the years, our mission has remained the same: to assist companies in navigating an increasingly competitive industry to achieve their full growth potential.